Rani Therapeutics Holdings Inc (NAS:RANI)
$ 2.51 0.03 (1.21%) Market Cap: 81.55 Mil Enterprise Value: 84.60 Mil PE Ratio: 0 PB Ratio: 23.08 GF Score: 32/100

Rani Therapeutics Holdings Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 08:00PM GMT
Release Date Price: $4.95 (+3.56%)
Srishti Kotiyal
Jefferies - Analyst

-- Jefferies Global Healthcare Conference. My name is Srishti Kotiyal with the Jefferies Investment Banking team. And it is my great pleasure to introduce Talat Imran, CEO, Rani Therapeutics.

Talat Imran
Rani Therapeutics Holdings, Inc. - CEO

Thank you so much. Can you hear me? Where's the clicker? Is it -- it's up there. Should I go up there? I think so. I can't see --

Unidentified Participant

Go ahead. Now you can see it.

Talat Imran
Rani Therapeutics Holdings, Inc. - CEO

Now I can see it. There we go. Hey, can everybody hear me? No? Sorry about that. Appreciate it. I think I'm the last presentation between you and cocktail hour, so I'll move this along as quickly as I can. Thank you so much for making the time and thank you to Jefferies for allowing us the opportunity to present.

As Shrishti said, my name is Talat Imran, I'm the CEO of Rani Therapeutics. Joined by our CFO, Svai Sanford. Rani Therapeutics is a clinical-stage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot